895
Views
38
CrossRef citations to date
0
Altmetric
Review

Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?

&
Pages 425-438 | Received 14 Jul 2016, Accepted 21 Oct 2016, Published online: 08 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rolf Teschke. (2018) Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Expert Opinion on Drug Metabolism & Toxicology 14:11, pages 1169-1187.
Read now
Ran Wang, Xingshun Qi, Eric M. Yoshida, Nahum Méndez-Sánchez, Rolf Teschke, Mingyu Sun, Xu Liu, Chunping Su, Jiao Deng, Han Deng, Feifei Hou & Xiaozhong Guo. (2018) Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review. Expert Review of Gastroenterology & Hepatology 12:4, pages 425-434.
Read now
Omar Shahbaz, Sandeep Mahajan & James H. Lewis. (2017) Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?. Expert Opinion on Drug Metabolism & Toxicology 13:9, pages 935-951.
Read now

Articles from other publishers (34)

A. E. Karateev. (2023) Personalized approach to choosing an analgesic for the treatment of musculoskeletal pain. Meditsinskiy sovet = Medical Council:21, pages 106-114.
Crossref
Nahum Méndez-Sánchez & Rolf Teschke. 2023. Comprehensive Guide to Hepatitis Advances. Comprehensive Guide to Hepatitis Advances 385 407 .
Qinglin Li, Shengkui Zhang, Miao Yu, Lihua Wang, Zhende Wang, Xiaohong Zhang, Yongbin Wang & Juxiang Yuan. (2022) Rotating night shift work and liver enzymes-associated abnormalities among steelworkers: a cross-sectional study from a Chinese cohort. International Archives of Occupational and Environmental Health 95:10, pages 1935-1944.
Crossref
Apichat Kaewdech, Siwanon Nawalerspanya, Suraphon Assawasuwannakit, Naichaya Chamroonkul, Sawangpong Jandee & Pimsiri Sripongpun. (2022) The use of Andrographis paniculata and its effects on liver biochemistry of patients with gastrointestinal problems in Thailand during the COVID-19 pandemic: a cross sectional study. Scientific Reports 12:1.
Crossref
Kayla Gelow, Sai Chalasani, Kelsey Green & Craig Lammert. (2021) Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients. Digestive Diseases and Sciences 67:7, pages 2891-2898.
Crossref
Xiao-Fei Peng, Shi-Feng Huang, Ling-Juan Chen, Lingqing Xu & Wen-Chu Ye. (2021) Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacological Research 172, pages 105846.
Crossref
Hongyan Zhu, Xintong Wang, Xiaoming Wang, Guixiang Pan, Yan Zhu & Yuxin Feng. (2021) The toxicity and safety of Chinese medicine from the bench to the bedside. Journal of Herbal Medicine 28, pages 100450.
Crossref
Thierry Gustot, Vanessa Stadlbauer, Wim Laleman, Carlo Alessandria & Mark Thursz. (2021) Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. Journal of Hepatology 75, pages S36-S48.
Crossref
William R. Treem, Melissa Palmer, Isabelle Lonjon-Domanec, Daniel Seekins, Lara Dimick-Santos, Mark I. Avigan, John F. Marcinak, Ajit Dash, Arie Regev, Eric Maller, Meenal Patwardhan, James H. Lewis, Don C. Rockey, Adrian M. Di Bisceglie, James W. Freston, Raul J. Andrade & Naga Chalasani. (2020) Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Safety 44:2, pages 133-165.
Crossref
Anwita Sinha, Shekhar Neema, Manish Manrai, Biju Vasudevan & S Radhakrishnan. (2021) Drug-induced liver injury: What a dermatologist should know?. Indian Journal of Drugs in Dermatology 7:2, pages 106.
Crossref
Li Wang, Huantian Cui, Yuting Li, Min Cao, Shanshan Man, Liying Guo, Jing Miao, Jianwei Jia, Yuhong Bian & Zhaiyi Zhang. (2020) Kang-Xian Pills Inhibit Inflammatory Response and Decrease Gut Permeability to Treat Carbon Tetrachloride-Induced Chronic Hepatic Injury through Modulating Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-14.
Crossref
Seyed Moayed Alavian, Zahra Parsian, Sarvin Sanaie, Ata Mahmoodpoor & Hassan Soleimanpour. (2020) Pain Management with Acetaminophen in Patients with Liver Diseases: A Review Article. Shiraz E-Medical Journal 22:8.
Crossref
Maneerat Chayanupatkul & Thomas D. Schiano. (2020) Acute Liver Failure Secondary to Drug-Induced Liver Injury. Clinics in Liver Disease 24:1, pages 75-87.
Crossref
Shuting Wang, Yanwan Shangguan, Cheng Ding, Pengcheng Li, Zhongkang Ji, Jundan Shao, Hong Fang, Meifang Yang, Pei Shi, Jie Wu, Jingjing Ren, Shigui Yang, Jing Yuan, Yunzhen Shi, Jingnan Li, Lanjuan Li & Kaijin Xu. (2018) Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury. Journal of International Medical Research 48:1, pages 030006051881151.
Crossref
Rolf Teschke & Gaby Danan. 2020. Liver Diseases. Liver Diseases 95 105 .
Rolf Teschke. (2019) Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Frontiers in Pharmacology 10.
Crossref
Juan Li, Ying-Ren Zhao & Zhen Tian. (2019) Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis. World Journal of Hepatology 11:5, pages 412-420.
Crossref
Miyako Kishimoto, Masayuki Adachi, Koichi Takahashi & Kazushige Washizaki. (2019) Clonazepam-induced liver dysfunction, severe hyperlipidaemia, and hyperglycaemic crisis: A case report. SAGE Open Medical Case Reports 7, pages 2050313X1984297.
Crossref
Meritxell Bellet, Faten Ahmad, Rafael Villanueva, Carolina Valdivia, Julián Palomino-Doza, Ada Ruiz, Xavier Gonzàlez, Encarna Adrover, Analía Azaro, Maria Valls-Margarit, Josep Lluís Parra, Juan Aguilar, Maria Vidal, Anastasi Martín, Joaquín Gavilá, Santiago Escrivá-de-Romaní, Antonia Perelló, Cristina Hernando, Ainhara Lahuerta, Pilar Zamora, Victoria Reyes, María Alcalde, Helena Masanas, Pamela Céliz, Isabel Ruíz, Miguel Gil, Miguel Àngel Seguí & Lorena de la Peña. (2019) Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication. Therapeutic Advances in Medical Oncology 11, pages 175883591983386.
Crossref
Jing Jing, Rui-lin Wang, Xin-yan Zhao, Yun Zhu, Ming Niu, Li-fu Wang, Xue-ai Song, Ting-ting He, Yong-qiang Sun, Wen-tao Xu, Si-miao Yu, Li-ping Wang, Yu-ming Guo, Zhao-fang Bai, Xiao-he Xiao & Jia-bo Wang. (2019) Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China . BMJ Open 9:1, pages e023567.
Crossref
Rolf Teschke. (2018) Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 6:4, pages 106.
Crossref
Toshio Arai, Kazutoyo Kogi, Yuki Honda, Takao Suzuki, Koji Kawai, Masako Okamoto, Takahiro Fujioka & Nobuhiro Murata. (2018) Lorazepam as a Cause of Drug-Induced Liver Injury. Case Reports in Gastroenterology 12:2, pages 546-550.
Crossref
Gaby Danan & Rolf Teschke. (2018) Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?. Drug Safety 41:8, pages 735-743.
Crossref
Rolf Teschke, Albrecht Wolff, Axel Eickhoff & Gaby Danan. (2018) Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?. JGH Open 2:4, pages 152-157.
Crossref
Rolf Teschke & Gaby Danan. (2018) Drug induced liver injury with analysis of alternative causes as confounding variables. British Journal of Clinical Pharmacology 84:7, pages 1467-1477.
Crossref
Hironao Okubo, Hitoshi Ando, Yushi Sorin, Eisuke Nakadera, Hiroo Fukada, Junichi Morishige, Akihisa Miyazaki & Kenichi Ikejima. (2018) Gadoxetic acid–enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C. PLOS ONE 13:4, pages e0196747.
Crossref
Rolf Teschke, Axel Eickhoff, Albrecht Wolff & Tran Dang Xuan. (2018) Liver Injury from Herbs and “Dietary Supplements”: Highlights of a Literature Review from 2015 to 2017. Current Pharmacology Reports 4:2, pages 120-131.
Crossref
Hai-Mei Zhao, Xiao-Yun Zhang, Xiu-Yun Lu, Song-Ren Yu, Xin Wang, Yong Zou, Zheng-Yun Zuo, Duan-Yong Liu & Bu-Gao Zhou. (2018) Erzhi Pill® Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway. Frontiers in Pharmacology 9.
Crossref
Antonios Douros, Laurent Azoulay, Hui Yin, Samy Suissa & Christel Renoux. (2018) Non–Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury. Journal of the American College of Cardiology 71:10, pages 1105-1113.
Crossref
Rolf Teschke & Gaby Danan. 2018. Drug-Induced Liver Toxicity. Drug-Induced Liver Toxicity 555 594 .
Aula Abbara, Sarah Chitty, Jennifer K. Roe, Rohma Ghani, Simon M. Collin, Andrew Ritchie, Onn Min Kon, John Dzvova, Harriet Davidson, Thomas E. Edwards, Charlotte Hateley, Matthew Routledge, Jim Buckley, Robert N. Davidson & Laurence John. (2017) Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC Infectious Diseases 17:1.
Crossref
Dieter Melchart, Stefan Hager, Sabine Albrecht, Jingzhang Dai, Wolfgang Weidenhammer & Rolf Teschke. (2017) Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World Journal of Hepatology 9:29, pages 1141-1157.
Crossref
Kennedy I. Amagon, Olufunsho Awodele & Abidemi J. Akindele. (2017) Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacology Research & Perspectives 5:5, pages e00360.
Crossref
Rolf Teschke, Johannes Schulze, Axel Eickhoff & Gaby Danan. (2017) Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?. International Journal of Molecular Sciences 18:4, pages 803.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.